Discovery Partnerships

Our Approach to Discovery Partnerships

Prous Institute’s core mission is to discover and develop competitive and safe preclinical drug candidates and include these in win-win co-development partnerships with industry.

Prous Institute responds efficiently to therapeutic challenges presented by our partners thanks to its fully integrated drug discovery and early development platform. The platform is built on medicinal chemistry and knowledge of the therapeutic areas, state-of-the-art proprietary in silico tools, all with strong backing by synthetic chemistry and pharmacology teams. This allows Prous Institute to offer excellent partnership project opportunities to industry.

Prous Institute's partnership opportunities fall under two project categories:

Prous Institute Pipeline Co-development Opportunities:

Our drug candidate co-development opportunities are based on proprietary and pre-validated preclinical SME drug candidate projects (see pipeline), each offered as specific and exclusive co-development opportunities to potential industry partners.

Discovery Solutions:

Our Discovery Solutions leverage our proprietary in silico tools (SYMMETRY® platform) and drug discovery knowledge (PSMEL® database) to generate unique and incisive prediction model building and screening projects that serve the needs of our partners. Our Discovery Solutions projects involve very specific chemical library screening techniques and the use of a large array of proprietary prediction models and validation methods. The goal is to substantially accelerate discovery stage steps and provide high quality hit and lead generation projects to our partners.